SCHEMBL2620727

SCHEMBL2620727

c1ccc(-c2oc3c4ccccc4c4ccccc4c3c2-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 1/20 0.46
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 3/20 0.43
ALOX15 P16050 2/20 0.43
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
GSK3B P49841 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
DDR2 Q16832 1/20 0.39
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
UBE2N P61088 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ABCG2 Q9UNQ0 2/20 0.37
PLA2G2A P14555 1/20 0.37
PLA2G4A P47712 1/20 0.37
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22954037 0.95 TNK2 (0.43) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL29597624 0.90 ALDH1A1 (0.42) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414859 0.90 ALDH1A1 (0.42) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414869 0.90 ALDH1A1 (0.42) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414547 0.87 TNK2 (0.38) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414599 0.87 TNK2 (0.38) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414592 0.87 TNK2 (0.38) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414953 0.87 TNK2 (0.38) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414576 0.86 TNK2 (0.38) TNK2ALDH1A1HSD17B10ALOX15CDK1
SCHEMBL22414654 0.86 CA1 (0.44) TNK2ALDH1A1CDK1CCNB1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2834284-B1 PHENANTHRO[9,10-B]FURAN POLYMERS AND SMALL MOLECULES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2017-05-10 EP disclosed
US-9505877-B2 Phenanthro[9,10-B]furan polymers and small molecules for electronic applications BASF SE (DE) 2016-11-29 US disclosed
US-9505877-B2 Phenanthro[9,10-B]furan polymers and small molecules for electronic applications BASF SE (DE) 2016-11-29 US disclosed
US-9079872-B2 Phenanthro[9, 10-B]furans for electronic applications BASF SE (DE) 2015-07-14 US disclosed
US-9079872-B2 Phenanthro[9, 10-B]furans for electronic applications BASF SE (DE) 2015-07-14 US disclosed
US-20150111337-A1 PHENANTHRO[9,10-B]FURAN POLYMERS AND SMALL MOLECULES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-04-23 US disclosed
US-20150111337-A1 PHENANTHRO[9,10-B]FURAN POLYMERS AND SMALL MOLECULES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-04-23 US disclosed
EP-2625171-B1 PHENANTHRO[9,10-B]FURANS FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-07-30 EP disclosed
WO-2013149897-A1 PHENANTHRO[9,10-B]FURAN POLYMERS AND SMALL MOLECULES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2013-10-10 WO disclosed
US-20120095222-A1 PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-04-19 US disclosed
US-20120095222-A1 PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-04-19 US disclosed
WO-2012045710-A1 PHENANTHRO[9,10-B]FURANS FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095222-A1 PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS P2RY10, P2RY11, P2RY12 TNK2 3697/4885ALDH1A1 1910/4885HSD17B10 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.